Human papilloma virus (HPV) integration signature in Cervical Cancer: identification of MACROD2 gene as HPV hot spot integration site

RAIDs Consortium

Research output: Contribution to journalArticleAcademicpeer-review

24 Citations (Scopus)
3 Downloads (Pure)

Abstract

Background: Cervical cancer (CC) remains a leading cause of gynaecological cancer-related mortality with infection by human papilloma virus (HPV) being the most important risk factor. We analysed the association between different viral integration signatures, clinical parameters and outcome in pre-treated CCs. Methods: Different integration signatures were identified using HPV double capture followed by next-generation sequencing (NGS) in 272 CC patients from the BioRAIDs study [NCT02428842]. Correlations between HPV integration signatures and clinical, biological and molecular features were assessed. Results: Episomal HPV was much less frequent in CC as compared to anal carcinoma (p < 0.0001). We identified >300 different HPV-chromosomal junctions (inter- or intra-genic). The most frequent integration site in CC was in MACROD2 gene followed by MIPOL1/TTC6 and TP63. HPV integration signatures were not associated with histological subtype, FIGO staging, treatment or PFS. HPVs were more frequently episomal in PIK3CA mutated tumours (p = 0.023). Viral integration type was dependent on HPV genotype (p < 0.0001); HPV18 and HPV45 being always integrated. High HPV copy number was associated with longer PFS (p = 0.011). Conclusions: This is to our knowledge the first study assessing the prognostic value of HPV integration in a prospectively annotated CC cohort, which detects a hotspot of HPV integration at MACROD2; involved in impaired PARP1 activity and chromosome instability.

Original languageEnglish
Pages (from-to)777-785
Number of pages9
JournalBritish Journal of Cancer
Volume124
Issue number4
Early online date16 Nov 2020
DOIs
Publication statusPublished - 16 Feb 2021

Bibliographical note

Funding Information:
Funding information This project has received funding from the European Union’s Seventh Program for research, technological development and demonstration under grant agreement no. 304810, the Fondation ARC pour la recherche contre le cancer, the Association d’aide à la recherche en Cancérologie de Saint-Cloud (ARCS), ICGex ANR-10-EQPX-03, and France Génomique ANR-10-INBS-09-08. Funding sources had no involvement in this study and this article.

Publisher Copyright:
© 2020, The Author(s).

Fingerprint

Dive into the research topics of 'Human papilloma virus (HPV) integration signature in Cervical Cancer: identification of MACROD2 gene as HPV hot spot integration site'. Together they form a unique fingerprint.

Cite this